Episode 1 led the investment round with backing from Superseed and angel investors.
"Most companies now realise that they can’t continue to compete without underpinning decision making with data but when looking to leverage a cloud data warehouse the choice they face is either outsource the processing of data to expensive agencies or hire data engineering and build this internally. With our platform, businesses can put the power of data engineering in the hands of their analysts and achieve a massive acceleration in value in a much shorter time while retaining the valuable knowledge about their own business logic in-house."
The company has received funding from Innovate UK to apply its artificial intelligence platform to glioblastoma multiforme research.
"The goal of GlamAI is to break new ground in applications of AI for drug discovery and accelerate the path to personalized medicine in labs around the world. We are very proud of the progress we’ve made so far to validate our approach. Through our partnership with King’s College London, GlamAI will collaborate with experts in glioblastoma multiforme and will secure access to disease cell-lines that best represent the tumor in patients. The funding received from Innovate UK is key to progress this highly innovative project and to accelerate the path to treatment for this deadly disease."
The digital health company raised the capital to scale its AI powered patient management platform and support remote care programmes.
"Greater Manchester is the only place in the UK that can provide us the data partnerships, research support, diverse population and integrated health and social care practices that will enable us to give healthcare professionals the control and trust in the unbiased intelligence that powers our patient management system."
Par Equity led the Series A round with participation from Mercia, Triplepoint, SIS Ventures, Scottish Enterprise and the MacLeod Family Trust.
"Our technology is already making a significant impact within counter terror and child sexual abuse investigations in the UK, and we're excited to build on this momentum in mainland Europe and the US. We've built a great network of partners to support our ambitious growth plans, and our team will double in size during each of the next two years to support this growth."
The Manchester-based delivery software provider secured backing from Chrysalis Investments to support product development and global expansion.
"We are delighted to provide Sorted with additional capital which will enable them to execute their ambition growth strategy. The recent pandemic has accelerated channel shift and Sorted are well placed to benefit from this trend, evidenced recently by some very exciting enterprise customer wins."
